We formulate APIs to maximize bioavailability, control release rate, and enhance stability.
We have been at the forefront of nanoparticle- and microparticle-based drug delivery since the early 1990s.
We are equipped to handle the complete development, characterization, and GMP manufacturing of your combination product.
We are adept at formulating and manufacturing large molecule therapies such as proteins, peptides, and oligonucleotides.
We have a number of patented technologies to utilize in tackling bioavailability and formulation challenges
LLS Health offers feasibility programs designed to accelerate product development in many areas.
At LLS Health, we know that formulating BCS Class II and IV compounds is not one-size-fits-all.
Our pre-clinical manufacturing services include R&D, engineering, and GLP test article manufacturing along with full analytical services.
Our manufacturing capabilities cover a variety of dosage forms, including powders, semi-solids, devices, solutions, and suspensions.
Our specialized team and purpose-built manufacturing facility ensure complex drug products get the care and focus needed to succeed.
Our well-designed, ICH-compliant stability programs accommodate a range of temperature and humidity conditions.
We are experts in complex sample preparation, and our experienced staff designs and executes phase-appropriate analytical strategies.
We have over two decades of experience developing and validating release assays for a variety of drug products and dosage forms.
We are adept at working with complex dosage forms and understand the importance of ensuring API stability.
We develop, optimize, and implement stability indicating methods to reliably measure product performance and support regulatory filings.